Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Edaravone Market Report 2017

  • QYR1683260
  • 104 Pages
  • October 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Edaravone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Edaravone in these regions, from 2012 to 2022 (forecast).

United States Edaravone market competition by top manufacturers/players, with Edaravone sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Mitsubishi Tanabe Pharma

Simcere

Taj Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Unichem Laboratories Ltd

UCB India Ltd

Piramal Healthcare

...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Oral

Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Edaravone for each application, including

Hospital

Clinic

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Edaravone Market Report 2017

1 Edaravone Overview

1.1 Product Overview and Scope of Edaravone

1.2 Classification of Edaravone by Product Category

1.2.1 United States Edaravone Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Edaravone Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Oral

1.2.4 Injection

1.3 United States Edaravone Market by Application/End Users

1.3.1 United States Edaravone Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 United States Edaravone Market by Region

1.4.1 United States Edaravone Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Edaravone Status and Prospect (2012-2022)

1.4.3 Southwest Edaravone Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Edaravone Status and Prospect (2012-2022)

1.4.5 New England Edaravone Status and Prospect (2012-2022)

1.4.6 The South Edaravone Status and Prospect (2012-2022)

1.4.7 The Midwest Edaravone Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Edaravone (2012-2022)

1.5.1 United States Edaravone Sales and Growth Rate (2012-2022)

1.5.2 United States Edaravone Revenue and Growth Rate (2012-2022)

2 United States Edaravone Market Competition by Players/Suppliers

2.1 United States Edaravone Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Edaravone Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Edaravone Average Price by Players/Suppliers (2012-2017)

2.4 United States Edaravone Market Competitive Situation and Trends

2.4.1 United States Edaravone Market Concentration Rate

2.4.2 United States Edaravone Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Edaravone Manufacturing Base Distribution, Sales Area, Product Type

3 United States Edaravone Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Edaravone Sales and Market Share by Region (2012-2017)

3.2 United States Edaravone Revenue and Market Share by Region (2012-2017)

3.3 United States Edaravone Price by Region (2012-2017)

4 United States Edaravone Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Edaravone Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Edaravone Revenue and Market Share by Type (2012-2017)

4.3 United States Edaravone Price by Type (2012-2017)

4.4 United States Edaravone Sales Growth Rate by Type (2012-2017)

5 United States Edaravone Sales (Volume) by Application (2012-2017)

5.1 United States Edaravone Sales and Market Share by Application (2012-2017)

5.2 United States Edaravone Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Edaravone Players/Suppliers Profiles and Sales Data

6.1 Mitsubishi Tanabe Pharma

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Edaravone Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Simcere

6.2.2 Edaravone Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Simcere Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Taj Pharmaceuticals Ltd.

6.3.2 Edaravone Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Sun Pharmaceutical Industries Ltd.

6.4.2 Edaravone Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Unichem Laboratories Ltd

6.5.2 Edaravone Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 UCB India Ltd

6.6.2 Edaravone Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 UCB India Ltd Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Piramal Healthcare

6.7.2 Edaravone Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Piramal Healthcare Edaravone Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

...

7 Edaravone Manufacturing Cost Analysis

7.1 Edaravone Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Edaravone

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Edaravone Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Edaravone Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Edaravone Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Edaravone Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Edaravone Sales Volume Forecast by Type (2017-2022)

11.3 United States Edaravone Sales Volume Forecast by Application (2017-2022)

11.4 United States Edaravone Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Edaravone

Figure United States Edaravone Market Size (K Units) by Type (2012-2022)

Figure United States Edaravone Sales Volume Market Share by Type (Product Category) in 2016

Figure Oral Product Picture

Figure Injection Product Picture

Figure United States Edaravone Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Edaravone by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Edaravone Market Size (Million USD) by Region (2012-2022)

Figure The West Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Edaravone Sales (K Units) and Growth Rate (2012-2022)

Figure United States Edaravone Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Edaravone Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Edaravone Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Edaravone Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Edaravone Sales Share by Players/Suppliers

Figure 2017 United States Edaravone Sales Share by Players/Suppliers

Figure United States Edaravone Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Edaravone Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Edaravone Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Edaravone Revenue Share by Players/Suppliers

Figure 2017 United States Edaravone Revenue Share by Players/Suppliers

Table United States Market Edaravone Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Edaravone Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Edaravone Market Share of Top 3 Players/Suppliers

Figure United States Edaravone Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Edaravone Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Edaravone Product Category

Table United States Edaravone Sales (K Units) by Region (2012-2017)

Table United States Edaravone Sales Share by Region (2012-2017)

Figure United States Edaravone Sales Share by Region (2012-2017)

Figure United States Edaravone Sales Market Share by Region in 2016

Table United States Edaravone Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Edaravone Revenue Share by Region (2012-2017)

Figure United States Edaravone Revenue Market Share by Region (2012-2017)

Figure United States Edaravone Revenue Market Share by Region in 2016

Table United States Edaravone Price (USD/Unit) by Region (2012-2017)

Table United States Edaravone Sales (K Units) by Type (2012-2017)

Table United States Edaravone Sales Share by Type (2012-2017)

Figure United States Edaravone Sales Share by Type (2012-2017)

Figure United States Edaravone Sales Market Share by Type in 2016

Table United States Edaravone Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Edaravone Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Edaravone by Type (2012-2017)

Figure Revenue Market Share of Edaravone by Type in 2016

Table United States Edaravone Price (USD/Unit) by Types (2012-2017)

Figure United States Edaravone Sales Growth Rate by Type (2012-2017)

Table United States Edaravone Sales (K Units) by Application (2012-2017)

Table United States Edaravone Sales Market Share by Application (2012-2017)

Figure United States Edaravone Sales Market Share by Application (2012-2017)

Figure United States Edaravone Sales Market Share by Application in 2016

Table United States Edaravone Sales Growth Rate by Application (2012-2017)

Figure United States Edaravone Sales Growth Rate by Application (2012-2017)

Table Mitsubishi Tanabe Pharma Basic Information List

Table Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Mitsubishi Tanabe Pharma Edaravone Sales Growth Rate (2012-2017)

Figure Mitsubishi Tanabe Pharma Edaravone Sales Market Share in United States (2012-2017)

Figure Mitsubishi Tanabe Pharma Edaravone Revenue Market Share in United States (2012-2017)

Table Simcere Basic Information List

Table Simcere Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Simcere Edaravone Sales Growth Rate (2012-2017)

Figure Simcere Edaravone Sales Market Share in United States (2012-2017)

Figure Simcere Edaravone Revenue Market Share in United States (2012-2017)

Table Taj Pharmaceuticals Ltd. Basic Information List

Table Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Taj Pharmaceuticals Ltd. Edaravone Sales Growth Rate (2012-2017)

Figure Taj Pharmaceuticals Ltd. Edaravone Sales Market Share in United States (2012-2017)

Figure Taj Pharmaceuticals Ltd. Edaravone Revenue Market Share in United States (2012-2017)

Table Sun Pharmaceutical Industries Ltd. Basic Information List

Table Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Sun Pharmaceutical Industries Ltd. Edaravone Sales Growth Rate (2012-2017)

Figure Sun Pharmaceutical Industries Ltd. Edaravone Sales Market Share in United States (2012-2017)

Figure Sun Pharmaceutical Industries Ltd. Edaravone Revenue Market Share in United States (2012-2017)

Table Unichem Laboratories Ltd Basic Information List

Table Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Unichem Laboratories Ltd Edaravone Sales Growth Rate (2012-2017)

Figure Unichem Laboratories Ltd Edaravone Sales Market Share in United States (2012-2017)

Figure Unichem Laboratories Ltd Edaravone Revenue Market Share in United States (2012-2017)

Table UCB India Ltd Basic Information List

Table UCB India Ltd Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure UCB India Ltd Edaravone Sales Growth Rate (2012-2017)

Figure UCB India Ltd Edaravone Sales Market Share in United States (2012-2017)

Figure UCB India Ltd Edaravone Revenue Market Share in United States (2012-2017)

Table Piramal Healthcare Basic Information List

Table Piramal Healthcare Edaravone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Piramal Healthcare Edaravone Sales Growth Rate (2012-2017)

Figure Piramal Healthcare Edaravone Sales Market Share in United States (2012-2017)

Figure Piramal Healthcare Edaravone Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Edaravone

Figure Manufacturing Process Analysis of Edaravone

Figure Edaravone Industrial Chain Analysis

Table Raw Materials Sources of Edaravone Major Players/Suppliers in 2016

Table Major Buyers of Edaravone

Table Distributors/Traders List

Figure United States Edaravone Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Edaravone Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Edaravone Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Edaravone Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Edaravone Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Edaravone Sales Volume (K Units) Forecast by Type in 2022

Table United States Edaravone Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Edaravone Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Edaravone Sales Volume (K Units) Forecast by Application in 2022

Table United States Edaravone Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Edaravone Sales Volume Share Forecast by Region (2017-2022)

Figure United States Edaravone Sales Volume Share Forecast by Region (2017-2022)

Figure United States Edaravone Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370